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Daniel Jiménez Fernández and Mohamed Lamkanfi*
Inflammatory caspases: key regulators 
of inflammation and cell death
Abstract: The innate immune system represents the first 
line of defence against infectious agents, and co-ordi-
nates cellular and molecular mechanisms that result 
in effective inflammatory and anti-microbial responses 
against pathogens. Infection and cellular stress trigger 
assembly of canonical and noncanonical inflammasome 
complexes that activate the inflammatory caspases-1 and 
-11, respectively. These inflammatory caspases play key 
roles in innate immune responses by inducing pyropto-
sis to halt intracellular replication of pathogens, and by 
engaging the extracellular release of pro-inflammatory 
cytokines and danger signals. In addition, the inflamma-
tory caspases-4, -5 and -11 were recently shown to directly 
bind microbial components. Although the immune roles 
of caspase-12 are debated, it was proposed to dampen 
inflammatory responses by interfering with caspase-1 
activation and other innate immune pathways. Here, we 
recapitulate the reported roles of inflammatory caspases 
with an emphasis on recent insights into their biological 
functions.
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Introduction
Cysteine-dependent aspartate-specific proteases (cas-
pases) comprise an evolutionary conserved family of 
metazoan proteases with well-established roles in apop-
tosis and inflammation (Lamkanfi et  al., 2002). They 
are broadly classified based on their demonstrated or 
assumed roles in apoptosis (caspases-2, -3, -6, -7, -8, -9 
and -10) and inflammatory signalling (caspases-1, -4, -5, 
-11 and -12). Caspase-14 is generally positioned outside of 
these apoptotic and inflammatory clusters because it is 
thought to be uniquely involved in terminal differentia-
tion of keratinocytes (Denecker et al., 2007; Hoste et al., 
2011; Seidelin et al., 2013).
Apoptotic caspases are further segregated into ‘initia-
tor’ and ‘executioner’ caspases based on their activation 
mechanisms. Initiator caspases (caspases-2, -8, -9 and 
-10) exist as latent zymogens that gain proteolytic activity 
upon their recruitment into multi-protein platforms that 
promote their proximity-induced autoactivation such as 
the death-inducing signalling complex (DISC) that acti-
vates caspases-8 and -10, and the apoptosome that drives 
caspase-9 activation, respectively (Bratton and Salvesen, 
2010; Lavrik and Krammer, 2012). In addition to other pro-
tease groups such as cathepsins and granzymes, initia-
tor caspases cleave the apoptotic executioner caspases-3, 
-6 and -7, the activation of which ultimately results in the 
emergence of the biochemical and morphological hall-
marks of apoptosis (Cornelis et al., 2007; Yazdi et al., 2010).
Caspase-12 was initially thought to promote endoplas-
mic reticulum stress-induced apoptosis (see below), but 
this and other inflammatory caspases (i.e. caspases-1, -11 
and -12 in rodents, and caspases-1, -4 and -5 in humans) 
are currently thought to be largely dispensable for apo-
ptosis signalling (Kuida et  al., 1995; Wang et  al., 1998). 
Instead, they are believed to control inflammatory and 
host defence responses during infection by modulating 
the maturation and secretion of inflammatory mediators, 
by inducing a lytic cell death mode termed pyroptosis, 
and by engaging other mechanisms that contribute to 
pathogen eradication (Lamkanfi, 2011).
In the next sections, we will separately review current 
understanding of the molecular activation mechanisms 
and (patho)physiological roles of each inflammatory 
caspase.
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Caspase-1 activation in canonical 
inflammasomes triggers cytokine 
release and pyroptosis
Caspase-1 was originally discovered for its ability to 
cleave and convert the inflammatory cytokine pro-inter-
leukin (IL)-1β into its bioactive form (Cerretti et al., 1992). 
Caspase-1 was subsequently shown to be the principal 
protease that processes proIL-1β and proIL-18 under most 
pathological conditions (Kuida et al., 1995; Li et al., 1995; 
Ghayur et al., 1997; Gu et al., 1997). However, additional 
mechanisms of proIL-1β maturation have recently been 
described (Guma et al., 2009; Joosten et al., 2009; Mayer-
Barber et al., 2010; Bossaller et al., 2012).
Caspase-1 itself is produced as a cytosolic precursor 
that undergoes proximity-induced autoactivation. Auto-
cleavage of human caspase-1 after D103 and D122 releases 
the linker that separates the amino-terminal caspase 
recruitment domain (CARD) from the catalytic domain. 
Removal of a second linker that is located inside the pro-
tease domain by cleavage after residues D297 and D316 
triggers conformational changes around the catalytic 
pocket that render the protease active (Elliott et al., 2009). 
Recent work with mouse caspase-1, however, has shown 
that caspase-1 autoprocessing is not a prerequisite for its 
activation. Recruitment of caspase-1 in large multi-protein 
complexes known as ‘canonical inflammasomes’ is suf-
ficient for its activation in the absence of autoprocessing 
(Broz et al., 2010b; Van Opdenbosch et al., 2014).
Several canonical inflammasomes have been charac-
terized in recent years, with those assembled by NLRP1, 
NLRP3, NLRC4, AIM2 and PYRIN among the best charac-
terized (Figure 1). The NLRs NLRP2, NLRP6, NLRP7 and 
NLRP12 have also been proposed to form inflammasomes, 
but further characterization is required to clarify the func-
tions of these complexes (Lamkanfi and Dixit, 2014).
The Nlrp1 inflammasomes
Nlrp1a is one of three murine Nlrp1 isoforms. They have 
in common that they are composed of an amino-terminal 
nucleotide-binding and oligomerization (NACHT) domain, 
a stretch of centrally located leucine-rich repeat (LRR) 
motifs followed by a function to find (FIIND) domain and 
a carboxy-terminal CARD motif with which they recruit 
caspase-1 (Masters et  al., 2012). Nlrp1a is expressed in 
haematopoietic progenitor cells, and has been impli-
cated in inflammasome assembly in response to infection 
Figure 1 Composition and effector mechanisms of canonical and 
noncanonical inflammasomes.
Canonical and noncanonical inflammasome pathways lead to 
cytokine secretion and cell death. Canonical inflammasomes such 
as the murine Nlrp1b, Nlrp3, Nlrc4, AIM2 and Pyrin lead to activa-
tion of caspase-1, which induces the secretion of the inflammatory 
cytokines IL-1β, IL-18 and pyroptosis. The murine NLRs (Nlrp1b, 
Nlrp3 and Nlrc4) harbour a NACHT domain followed by a variable 
number of LRRs, as well as an N-terminal CARD or PYD motif. Addi-
tionally, Nlrp1b contains a FIIND domain but lacks the PYD domain 
found in the human NLRP1 inflammasome. The murine gene MEFV 
encodes PYD at the N-terminus which facilitates interaction with 
other domains, followed by a B-box domain. AIM2 contains a PYD 
domain at the N-terminus followed by a HIN200 domain. The protein 
adaptor ASC is required for the assembly of Nlrp3, AIM2 and Pyrin 
inflammasome. Activation of the noncanonical inflammasome is 
mediated by caspase-11 and it will either trigger pyroptosis directly 
or activate the canonical Nlrp3 inflammasome leading to secretion 
of the inflammatory cytokines IL-1β and IL-18.
(Masters et al., 2012). Nlrp1a activation triggers pyroptosis 
and release of bioactive IL-1β, excessive secretion of which 
may result in neutrophilia.
The Nlrp1b inflammasome activates caspase-1 in 
murine macrophages that have been intoxicated with 
lethal toxin (LeTx) of Bacillus anthracis, the causative 
agent of anthrax (Boyden and Dietrich, 2006). LeTx is 
a bipartite toxin that consists of the protective antigen 
(PA) and lethal factor (LF) subunits. PA is a pore-forming 
protein that protects LF from degradation in phagolyso-
somes by shuttling it into the cytosol of intoxicated cells 
(Bann, 2012). The metalloprotease activity of LF is required 
to induce Nlrp1b inflammasome-mediated pyroptosis and 
to promote secretion of IL-1β and IL-18 (Fink et al., 2008). 
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Interestingly, the central FIIND domain of Nlrp1b spon-
taneously undergoes autocatalytic cleavage, which was 
shown to be critical for subsequent LeTx-induced inflam-
masome activation (Frew et  al., 2012). Moreover, dele-
tion of the inflammasome adaptor apoptosis-associated 
speck-like protein containing CARD (ASC) blocked LeTx-
induced capase-1 autoprocessing, but not the Nlrp1b- and 
caspase-1-dependent induction of pyroptosis and IL-1β 
secretion (Van Opdenbosch et al., 2014). This shows that 
caspase-1 autoprocessing is not critical for caspase-1 acti-
vation, although it may further enhance protease activity 
by locking caspase-1 in an active conformation.
Unlike rodents, humans express a single NLRP1 
isoform. The human ortholog differs from its murine coun-
terparts in that it contains an additional pyrin motif at the 
amino-terminus (D’Osualdo and Reed, 2012). Mutations 
in NLRP1 are associated with vitiligo-associated autoim-
mune disease (Jin et  al., 2007), autoimmune Addison’s 
disease (Zurawek et al., 2010) and type I diabetes (Magitta 
et al., 2009). However, more work is needed to clarify the 
underlying molecular mechanisms by which these muta-
tions trigger autoimmunity.
The Nlrp3 inflammasome
The Nlrp3 inflammasome arguably is the most studied 
inflammasome. It is implicated in host defence against a 
wide range of bacterial (Staphylococcus aureus, Escheri-
chia coli, Citrobacter rodentium) (He et al., 2010; Gurung 
et al., 2012), viral (influenza A) (Allen et al., 2009; Thomas 
et al., 2009), fungal (Candida albicans, Aspergillus fumi-
gates; Gross et al., 2009) and parasitic (Leishmania ama-
zonensis) infections (Lamkanfi and Dixit, 2012; Lima et al., 
2013). In addition, the Nlrp3 inflammasome is activated by 
damage-associated molecular patterns (DAMPs) such as 
adenosine triphosphate (ATP), uric acid crystals, amyloid 
β fibrils and hyaluronan that are thought to trigger inflam-
mation under sterile conditions. Also exogenous crystal-
line particles and inhaled nanomaterials such as cigarette 
smoke, diesel exhaust particles and silica activate this 
inflammasome, suggesting possible roles in pulmonary 
inflammation (Brusselle et al., 2014).
Unlike blood monocytes that activate the Nlrp3 
inflammasome in response to TLR ligands alone (Netea 
et al., 2009), it is now well-established that activation of 
the Nlrp3 inflammasome requires two signals in murine 
macrophages. Owing to its low basal expression levels 
in the latter cells, a priming signal is firstly required to 
promote the nuclear factor kappa-light-chain-enhancer 
of activated B cells (NF-κB)-dependent transcriptional 
upregulation of Nlrp3 (Bauernfeind et  al., 2009). Recent 
work also suggested transcription-independent mecha-
nisms of Nlrp3 priming (Juliana et al., 2012; Schroder et al., 
2012). However, neither of these signals is sufficient to acti-
vate the Nlrp3 inflammasome by themselves. The infec-
tious agents, DAMPs and crystalline particles mentioned 
above are thought to trigger a common signal that acti-
vates the Nlrp3 inflammasome. Several molecular mech-
anisms have been described, including the extracellular 
release of K+ ions (Muñoz-Planillo et al., 2013), the release 
of oxidized DNA from damaged  mitochondria (Zhou et al., 
2011), cytosolic release of lysosomal  cathepsins (Hornung 
et  al., 2008), translocation of Nlrp3 to mitochondria 
(Misawa et  al., 2013) and cardiolipin  recognition in the 
cytosolic compartment (Iyer et  al., 2013). However, the 
precise mechanisms of Nlrp3 activation remain a topic of 
intense research, and future work will undoubtedly shed 
more light on this aspect.
Activation of the Nlrp3 inflammasome is of clinical rel-
evance because mutations in NLRP3 cause three hereditary 
periodic fever syndromes that are collectively referred to 
as cryopyrin-associated periodic fever syndromes (CAPS). 
These autosomal dominant gain-of-function mutations in 
NLRP3 may cause conformational changes in NLRP3 that 
result in the loss of autoinhibitory mechanisms (Lu et al., 
2014). In addition to these rare autoinflammatory syn-
dromes, defective NLRP3 inflammasome activation has 
been implicated in common autoimmune diseases such 
as inflammatory bowel disease (Villani et al., 2009; Zaki 
et  al., 2011), Alzheimer’s disease (Heneka et  al., 2013), 
age-related macular degeneration (Doyle et al., 2012) and 
several other ailments (Lamkanfi and Dixit, 2012, 2014).
The AIM2 inflammasome
Whereas NLRP1 and NLRP3 are NLRs, absent in melanoma 
2 (AIM2) is a cytosolic member of the intracellular HIN200 
receptor family. Binding of dsDNA to its HIN200 domain 
triggers assembly of an inflammasome that contains ASC 
and caspase-1. AIM2 inflammasome activation contributes 
to host defence against intracellular bacterial pathogens 
such as Listeria monocytogenes and Francisella tularensis 
as well as against a subset of DNA viruses that includes 
vaccinia virus and cytomegalovirus (Fernandes-Alnemri 
et  al., 2010; Jones et  al., 2010; Rathinam et  al., 2010; 
Tsuchiya et al., 2010).
Interestingly, AIM2 was originally discovered as a 
protein that was markedly downregulated in a substantial 
set of melanoma and other cancer cells (Lee et al., 2012). 
Although the precise roles of AIM2 in carcinogenesis have 
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remained obscure, these observations suggest that it may 
act as a tumor suppressor. Interestingly, de regulated 
AIM2 expression has also been linked to systemic lupus 
 erythematosus (SLE) and psoriasis (Dombrowski et  al., 
2011; Zhang et al., 2013), although studies in larger patients 
groups are needed to further substantiate a causal rela-
tionship and to shed light on the mechanisms by which its 
absence causes autoimmunity.
The Nlrc4 inflammasome
Caspase-1 is activated by the Nlrc4 inflammasome upon 
infection with intracellular pathogens such as Salmonella 
enterica serovar Typhimurium (Salmonella  Typhimurium), 
Pseudomonas aeruginosa, Legionella pneumophila, Shi-
gella flexneri and Burkholderia thailandensis (Lamkanfi 
and Dixit, 2012). These pathogens have in common that 
they express flagellin – the principal component of bacte-
rial flagella – and/or specialized type III secretion systems 
(Lamkanfi and Dixit, 2014). These bacterial factors are 
recognized by members of the NAIP proteins, which act 
upstream of Nlrc4 in inflammasome activation (Kofoed 
and Vance, 2011; Zhao et  al., 2011). In addition to these 
NAIP proteins, S. Typhimurium- and flagellin-induced 
caspase-1 activation was shown to require phosphoryla-
tion of Nlrc4 on Ser533 (Qu et al., 2012). As in the Nlrp1b 
inflammasome, ASC was dispensable for Nlrc4 inflam-
masome-induced pyroptosis induction, but required for 
caspase-1 autoprocessing (Broz et al., 2010b; Van Opden-
bosch et  al., 2014). Interestingly, these inflammasomes 
differed in their requirement for ASC for cytokine secre-
tion because ASC-deficient macrophages were severely 
hampered in their ability to secrete mature IL-1β and IL-18 
when infected with S. Typhimurium (Mariathasan et al., 
2004; Broz et  al., 2010b; Van Opdenbosch et  al., 2014). 
Recent work demonstrated that the ASC CARD domain 
has prion-like characteristics (Cai et  al., 2014; Lu et  al., 
2014), in line with the observation that inflammasome-
activating agents trigger formation of ‘ASC specks’, large 
filamentous structures in the perinuclear region of cells 
that were treated with inflammasome-activating agents 
(Broz et al., 2010a,b; Jones et al., 2010; Van Opdenbosch 
et al., 2014). Detailed analysis of the physiological role of 
these specks is somewhat hampered by the fact that ASC 
is critical for assembly of the Nlrp3 and AIM2 inflamma-
somes themselves (Sagulenko et al., 2013). Although ASC 
is required for caspase-1 automaturation, ASC specks are 
unlikely to be directly required for inflammasome-driven 
pyroptosis and cytokine secretion because ASC was not 
essential for Nlrp1b-mediated cytokine secretion, nor 
for Nlrp1b- and Nlrc4-mediated pyroptosis (Mariathasan 
et  al., 2004; Broz et  al., 2010b; Van Opdenbosch et  al., 
2014). Recent work has shed light on the possible roles of 
ASC specks by demonstrating that extracellular release of 
ASC specks from pyroptotic cells promoted inflammation 
by extending the maturation of caspase-1 and IL-1β to the 
extracellular milieu and surrounding cells that have inter-
nalized specks, as well as by enhancing the recruitment 
of neutrophils that contribute to the release of additional 
inflammatory mediators (Baroja-Mazo et al., 2014; Frank-
lin et al., 2014).
The Pyrin inflammasome
Mutations in the Pyrin-encoding gene MEFV cause famil-
ial Mediterranean fever (FMF), the most prevalent auto-
inflammatory disease (Bernot et  al., 1997; Consortium, 
1997). Pyrin is composed of an amino-terminal PYD 
domain, centrally located zinc-finger B-box and coiled-
coil domains, and a carboxy-terminal B30.2 domain. The 
amino-terminal PYD domain was shown to interact with 
ASC, and the C-terminal B30.2 domain with caspase-1 in 
overexpression studies (Chae et al., 2006, 2008). In agree-
ment, Pyrin was shown to assemble an ASC- and caspase-
1-containing inflammasome in response to infection with 
Burkholderia cenocepacia, an opportunistic pathogen 
that causes respiratory inflammation in cystic fibrosis 
patients (Gavrilin et  al., 2012). More recently, Pyrin was 
demonstrated to sense the Rho-glucosylating activity of 
cytotoxin (TcdB) of Clostridium difficile, a pathogen that 
causes nosocomial diarrhoea (Xu et al., 2014). Pyrin also 
triggered inflammasome activation by Rho-inactivating 
toxins of Vibrio parahaemolyticus, Histophilus somni, 
Clostridium botulinum and upon B. cenocepacia infec-
tion. In agreement, the Pyrin inflammasome proved to 
be critical for controlling intra-macrophage growth of B. 
cenocepacia, and Pyrin-deficient mice were markedly pro-
tected from B. cenocepacia-induced lung inflammation 
(Xu et al., 2014).
Caspase-11: a cytosolic sensor 
of lipopolysaccharides
Caspase-11 is produced as isoforms of 42 and 38 kDa, both 
originating from the caspase-11 gene that is located in the 
inflammatory caspase locus on chromosome 9 (Wang 
et  al., 1996). The 38  kDa isoform likely arises from the 
usage of an alternative start codon because both isoforms 
Brought to you by | Universiteit Gent
Authenticated
Download Date | 2/6/15 2:56 PM
D.J. Fernández and M. Lamkanfi: Inflammatory caspases      197
are produced upon transient transfection of a mouse 
caspase-11 cDNA-expressing plasmid in L929 cells (Kang 
et  al., 2000). Human caspases-4 and -5 are duplicated 
counterparts of murine caspase-11 (Lamkanfi et al., 2002). 
These human homologs share a sequence homology of 
60% and 55% in relation to murine caspase-11, respec-
tively, at the protein level, the highest between inflam-
matory caspases. Mouse caspase-11 and caspase-4 have 
in common that their mRNAs have a similar tissue dis-
tribution. Caspase-11 mRNA is ubiquitously expressed in 
many organs and its protein expression is predominant in 
skeletal muscle, heart and brain (Kalai et al., 2003). Con-
versely, caspase-11 and human caspase-5 both have low 
basal expression levels in naive macrophages, and both 
are highly upregulated by lipopolysaccharides (LPS) and 
interferon-gamma (IFN-γ) (Van de Craen et al., 1997; Lin 
et al., 2000; Lamkanfi et al., 2002).
Although further work is needed to establish which 
of the two human paralogues represents the functional 
counterpart of mouse caspase-11, significant progress was 
recently made in understanding the (patho)physiological 
roles of caspase-11. LPS-stimulated bone marrow-derived 
macrophages (BMDMs) of caspase-11-/- mice were defective 
in IL-1β secretion when exposed to cholera toxin b (CtB) or 
when infected with Gram-negative enteropathogens such 
as C. rodentium, Vibrio cholerae and E. coli (Kayagaki et al., 
2011). Subsequent studies demonstrated that caspase-11 
expression and activation downstream of Toll-like recep-
tor 4- (TLR) and TIR-domain-containing adapter-inducing 
IFN-β (TRIF)-dependent production of type I interferons 
contributed to IL-1β production by a broad array of Gram-
negative bacterial pathogens (Broz et  al., 2012; Gurung 
et al., 2012; Rathinam et al., 2012). In contrast, caspase-
11 was dispensable for IL-1β secretion by Gram-positive 
bacteria. Caspase-11 is unable to mature proIL-1β itself, 
but triggers caspase-1 activation by the ‘canonical’ Nlrp3 
inflammasome to induce IL-1β production (Kayagaki et al., 
2011). Indeed, NLRP3, ASC and caspase-1 were dispensa-
ble for caspase-11 activation, but they were critical for C. 
rodentium- and E. coli-induced IL-1β secretion (Kayagaki 
et al., 2011).
Unlike IL-1β secretion, caspase-11 induced pyroptotic 
cell death of infected cells autonomously, without a require-
ment for a functional Nlrp3 inflammasome (Kayagaki 
et al., 2011). Pyroptosis is considered a pro-inflammatory 
cell death mode that is characterized by early cell lysis and 
release of the intracellular content into the surrounding 
tissue. Concomitant with the secretion of the inflammatory 
cytokines IL-1β and IL-18 by canonical inflammasomes, the 
release of DAMPs such as S100 proteins and high mobility 
group box1 (HMGB1) promotes inflammation (Lamkanfi, 
2011). This cell death mode has been proposed as an 
efficacious mechanism to clear intracellular pathogens 
(Miao et  al., 2011; Broz et  al., 2012). Pyroptosis has been 
observed in monocytes, macrophages and dendritic cells 
when infected with S. Typhimurium, F. tularensis, L. pneu-
mophila and B. anthracis, but also occurs upon inflamma-
some activation by non-infectious agents (Broz et al., 2012; 
Gurung et al., 2012; Rathinam et al., 2012).
Interestingly, caspase-11 activation was induced spe-
cifically by the acylated lipid A component of LPS in most 
Gram-negative bacteria, explaining why caspase-11 spe-
cifically reacted to intracellular Gram-negative pathogens. 
Notably, synthetic lipid A and LPS isolated from E. coli- 
and S. Typhimurium-activated caspase-11 independently 
of the established membrane-bound LPS receptor TLR4 
(Hagar et al., 2013; Kayagaki et al., 2013). Instead, caspase-
11 activation required LPS to be present in the cytosolic 
compartment (Hagar et  al., 2013; Kayagaki et  al., 2013). 
This observation suggested the existence of an intracellu-
lar LPS-sensor that triggers caspase-11 activation. In agree-
ment, recent work showed the CARD motif of recombinant 
caspase-11 to bind LPS specifically and with high affinity 
(Figure 1), suggesting caspase-11 to act both as the LPS-
sensor and -effector in infected macrophages (Shi et al., 
2014). Indeed, caspase-11-/- mice were more resistant to 
LPS-induced lethality (Wang et al., 1998; Kayagaki et al., 
2011). Moreover, caspase-11 activation contributed impor-
tantly to LPS-induced lethality of TLR4-deficient mice 
that had been pre-stimulated with non-lethal doses of the 
TLR3 agonist polyinosinic:polycytidylic acid (polyI:C) to 
induce caspase-11 expression (Hagar et al., 2013; Kayagaki 
et al., 2013). In contrast, a high percentage of caspase-11-
/- mice survived this treatment regimen. Thus, caspase-11 
contributed to LPS-induced lethality independently of 
TLR4 and caspase-1. Concurrently, caspase-11-induced 
pyroptosis was proposed to mediate host defence against 
intracellularly-replicating Gram-negative bacteria (Hagar 
et al., 2013; Kayagaki et al., 2013), and to protect against 
dextran-sodium sulfate (DSS)-induced colitis (Demon 
et  al., 2014). The identification of biomarkers for pyrop-
tosis may shed further light on how caspase-11-mediated 
pyroptosis modulates pathology of infectious and non-
infectious diseases in vivo.
Caspase-12: a negative regulator 
of immune signalling
The geographic distribution of caspase-12 expression in 
humans has intrigued investigators for nearly a decade 
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(Saleh et al., 2004; Kachapati et al., 2006; Xue et al., 2006; 
Ferwerda et al., 2009; Hervella et al., 2012). Remarkably, 
full-length caspase-12 (Casp12L) is absent in Caucasians, 
but expressed in some ethnic groups living in North and 
Sub-Saharan Africa, together comprising 20–30% of the 
African population (Kachapati et  al., 2006; Xue et  al., 
2006). In addition, the Casp12L allele is found in popu-
lations of the Middle East and South-East Asia, albeit at 
lower frequencies (Kachapati et al., 2006; Hervella et al., 
2012). Casp12L is also found in a fraction of the African-
American population that was suggested to be more sus-
ceptible to septic shock (Saleh et  al., 2004), although 
another study failed to detect significant differences in 
TLR ligand-induced inflammatory cytokine expression 
profiles of haematopoietic cells from individuals express-
ing Casp12L or the short isoform of caspase-12 (Casp12S) 
(Ferwerda et al., 2009).
The loss of Casp12L in Europe predates a domestic life-
style because genotyping of tooth samples of 24 pre-Neo-
lithic individuals from six archaeological sites in Spain 
showed that they were all homozygous for a C > T single 
nucleotide polymorphism (SNP; rs497116) that gives rise 
to Casp12S that largely corresponds to its amino-terminal 
CARD domain (Fischer et al., 2002; Hervella et al., 2012). 
The fixation of the Casp12S allele in Caucasians, large 
parts of Africa, the Americas and Asia suggested that it 
conferred a selective advantage against bacterial infec-
tions or other environmental factors soon after its emer-
gence in Africa 100  000–500  000  years ago (Xue et  al., 
2006). However, the precise environmental factors that 
drove the Casp12S allele to near-fixation during human 
evolution remain unclear (Ferwerda et al., 2009). Remark-
ably, this selective pressure is unlikely to involve caspase-
12 proteolytic activity because both the Casp12L and 
Casp12S alleles contain an additional missense mutation 
that converted the catalytic SHG motif found in other cas-
pases to an SHS motif in human caspase-12 (Fischer et al., 
2002). When introduced in human caspase-1, this muta-
tion prevented cleavage of proIL-1β into its mature form, 
confirming the critical importance of this evolutionary 
conserved motif for caspase activity (Rocher et al., 1997). 
Interestingly, although mouse caspase-12 has an intact 
SHG motif, no validated substrates have been reported 
for the recombinant protease apart from it undergoing 
autocleavage after D319 into separate 20 kDa and 10 kDa 
catalytic subunits upon its production in E. coli (Roy et al., 
2008). While this may suggest that a co-factor is required 
for its optimal activation, it has also raised the possibility 
that – as in humans – mouse caspase-12 may regulate cel-
lular processes by interfering with protein-protein interac-
tions in multi-protein complexes.
The roles and signalling mechanisms of caspase-12 
are not fully understood. Caspase-12 was originally pro-
posed to be critical for endoplasmic reticulum (ER) stress-
induced apoptosis (Nakagawa et al., 2000), but this has 
been contested by other studies (Kalai et al., 2003; Saleh 
et  al., 2006). More recently, caspase-12 was proposed to 
negatively regulate inflammasome activation by recruiting 
caspase-1 away from its activating complexes (Saleh et al., 
2006). In agreement, caspase-12-deficient splenocytes 
had increased production of mature IL-1β and IL-18 when 
stimulated with TLR ligands (Saleh et al., 2006). In addi-
tion, caspase-12 knockout mice were found to be hyper-
susceptible to LPS-induced endotoxemia. These mice 
were also shown to be more resistant to septic shock when 
subjected to the colon ascendens stent peritonitis (CASP) 
model because they cleared the infection more efficiently 
than wild-type controls (Saleh et al., 2006). De-repression 
of inflammasome signalling in caspase-12-deficient mice 
also was proposed to promote resistance to DSS-induced 
colitis (Dupaul-Chicoine et al., 2010).
In another study from these investigators, cecum and 
colon samples of caspase-12-deficient mice were found to 
harbour up to 10-fold higher levels of the anti-microbial 
peptide β-defensin 1 relative to control C57BL/6 mice 
(LeBlanc et al., 2008). Regulation of β-defensin 1 expres-
sion by caspase-12 was not a result of differential caspase-1 
regulation and IL-1β production, but rather involved mod-
ulation of NOD1/2 signalling. Caspase-12 was shown to 
recruit the NOD1/2-adaptor kinase RIP2. The absence of 
caspase-12 thus increased NOD1/2-mediated activation of 
mitogen-activated protein (MAP) kinase and NF-κB sig-
nalling in the gastro-intestinal tract (LeBlanc et al., 2008). 
Caspase-12 knockout mice were demonstrated to clear the 
malaria parasite Plasmodium chabaudi better than control 
mice because of increased cytokine production in the 
absence of caspase-12 (Labbe et  al., 2010). This was not 
because of enhanced inflammasome and NOD1/2 signal-
ling, but rather because NF-κB activation was increased in 
the absence of caspase-12-mediated sequestration of the 
central NF-κB modulator IκB kinase (IKK)γ/NEMO (Labbe 
et al., 2010). Caspase-12 also was shown to contribute to 
effective host defence responses against West Nile Virus 
(WNV) infection by enhancing type I interferon produc-
tion by the intracellular RNA receptor RIG-I (Wang et al., 
2010). Consequently, caspase-12-deficient mouse embry-
onic fibroblasts had reduced IFN-β levels and increased 
viral titers when challenged with WNV (Wang et al., 2010).
In conclusion, caspase-12 appears to employ a diverse 
set of molecular mechanisms to modulate innate immune 
signalling: it inhibits inflammasomes by sequestering 
caspase-1, it dampens NOD1/2 signalling by recruiting 
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RIP2, and it prevents activation of the inflammatory tran-
scription factor NF-κB at the level of the IKK complex 
(Figure 2). In contrast, caspase-12 contributed positively to 
WNV-induced type I IFNs production upstream of RIG-I. 
Further work is needed to fully understand the spatio-
temporal factors that define the molecular mechanisms 
by which caspase-12 modulates inflammation and host 
defence responses in vivo.
Concluding remarks
Over the past years, research into the mechanisms and 
immune roles of inflammatory caspases uncovered new 
functions of these proteases and revealed the signalling 
pathways in which they operate. Recruitment of caspase-1 
Figure 2 Schematic depiction of proposed caspase-12 effector 
mechanisms.
(A) Upon bacterial infection, the CARD domain of the pattern 
recognition receptor NOD2 establishes a homotypic CARD-CARD 
interaction with the CARD domain of RIP2 kinase. Next, the ubiquitin 
E3-ligases cIAP1 and -2 interact with RIP2 and conjugate K63-poly-
ubiquitin chains to the RIP2 kinase domain, leading to NF-κB activa-
tion. Caspase-12 dampens the NOD2-RIP2 interaction by displacing 
TRAF6 from RIP2 and consequently reducing the inflammatory 
response by dampening NF-κB activation. (B) The NLRP3 inflam-
masome and its regulation by caspase-12 as a dominant negative 
regulator are depicted. (C) Caspase-12 inhibits NF-κB signalling by 
targeting the IKK complex. Caspase-12 displaces NEMO from the 
complex, leading to an inadequate assembly of the IKK complex. 
(D) Upon WNV infection, caspase-12 modulates TRIM25-mediated 
ubiquitination of RIG-I, thus leading to enhanced type I interferon 
production.
in multi-protein complexes termed inflammasomes seems 
sufficient for it to become activated without the neces-
sity of autoprocessing. The Pyrin inflammasome now 
also is better understood and was demonstrated to trigger 
inflammasome activation by B. cenocepacia or Rho-inac-
tivating toxins of V. parahaemolyticus. Caspase-11 was 
shown to sense intracellular LPS directly and to induce 
pyroptosis, thus preventing replication of Gram-negative 
pathogens. In addition, caspase-11 was shown to contrib-
ute to LPS-induced lethality in the absence of TLR4 and 
to contribute to host defence against E. coli, C. rodentium, 
S.   Typhimurium and S. flexneri. Finally, caspase-12 was 
proposed to modulate immune signalling through diverse 
molecular mechanisms, but it is generally believed to play 
an inhibitory role in the innate immune system.
Despite such rapid progress in our understanding of 
these key inflammatory proteases, many questions remain 
unanswered. For instance, the molecular mechanisms 
leading to activation of the Nlrp3 inflammasome remain 
unclear. The mechanism by which caspase-11 drives 
pyroptosis, and how it modulates pathology of infectious 
and non-infection diseases in vivo require further work. 
Finally, the roles of caspase-12 remain incompletely under-
stood, and further analysis of the signalling mechanisms 
and physiological roles of this caspase will undoubtedly 
break new ground.
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